| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |